Trial intelligence / Profile preview

Intravenous Tranexamic Acid During Myomectomy

NCT02620748Phase 1Completed

Sponsor
George Washington University
Start
Mar 2015
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of tranexamic acid in uterine leiomyoma (2 arms), sponsored by George Washington University. Primary endpoint: Intraoperative Estimated Blood Loss. Started Mar 2015; status: completed.

02

Drugs

tranexamic acid
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT02620748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02620748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call